Member Info for VikR

Following the investor presentation it is nice to know the honesty and admirable hard work the team have been doing in securing new contracts. This is massively overdue a rerate. I have invested in a few science biotech projects here with FAB,SVNS, IMM to name a few. PYC seems a good long term buy and will turn the corner at some point and transition upwards.

Remain vested astute investors

As has been mentioned over the preceding few weeks there is tremendous clinical asset potential of the entire portfolio these people have. When that is coupled with the BoD we have you cannot get a better EVIDENCED BASED BUY. There seems to have been some historical nonsense these last few days, a mere ploy to drag it down and fill there own orders cheaper. When this happens one should take it as an extreme positive when people start playing games to accumulate.

My scientific and clinical opinion as a prescriber of the clinical areas these guys operate in has my full backing, approval and endorsement

Drop in volume the weekend before the last bank holiday is to be expected. The long term trajectory remains intact though. Good to know there is a multitude of long term holders with at least 1 million plus shares which are not selling a single share during the yo yo up and down cycle. Astute investors know the real deal when this shoots to the first stop at 50p before triple figures

Can someone educate me compared to what Mila have please

Just had my question answered on the FAB hub. The whole team is heading towards the formal launch in December at the San Diego conference for Optimal. The Philadelphia conference attracted a lot of interest from industry delegates laying the foundations for commercialisation. With this in mind expect validation from NCI to land soon and some commercial updates on Optimal along the way. In regards to the other facets of the business to me those are just supernumerary at this stage (but it all adds up to the bottom line).

What super fantastic news for long term holders.

These recent few penny drops are insignificant in the wider picture and material re rate which is on the way. I for one will not be selling a single penny under £1

Stay vested astute investors these new optimal mammalian antibodies are going to change science forevermore. 🚀🚀🚀

Another top up done just now, happy buying everyone

Nice to see that back in April 2025 SVNS have engaged the use of pharmaventures who specialise in solely commercialisation of assets. They have completed a 1000 deals to date, seem to have been in operation since 1997 according to companies house. Regulated by the FCA and some decent directors on the board. Some links attached FYI to research freely at your leisure.

Cements my sentiment and belief even further

https://www.lse.co.uk/rns/engagement-of-pharmaventures-bd5rpri0mnoc3wa.html

https://www.pharmaventures.com/

I echo your sentiment James and with the SP historically much higher without the recent news this is a very relaxed hold and wait for completion to fruition

Stay relaxed and invested astute investors, positive news will come

At worst this will become a solid hold for the patient investors should the aforementioned deadlines be missed. The long term reward should outweigh any short term ‘drama’

Https://youtu.be/jlxz6E1ZBro?si=pC9thnAwBQoTZSQP

New era of massive investment into the neurological sector

M&A in this arena is massive, lots of lucrative deals done in the last 24 months. The reason it’s such a big area it’s because we prescribe so much in it in the UK alone. For example for every 10 patients I see at least 2 of them will suffer from anxiety/depression or some other focal neurology.

‘Big Pharma loves de-risked assets’ - direct quote from our chair. We have phase II and III assets in situ ready to go. The biggest no brainer buy that has existed this year for me.

Follow the evidence base astute investors and I am sure you will draw the same conclusions

Some very valid points succinctly put and good evidence based comparisons. Definitely agree with the UNCAPPED potential. This is what makes this share even more exciting when you don’t know if it is going to hit triple or quadruple figures in its unilateral upward spike. Either way everybody wins and UK science proudly leads the world antibody platform

Convinced my dad to use his stocks and shares ISA yesterday, went for the safest option in my opinion and put it in here for him. Hopefully I can give him some good news before the end of the year with some commercialisation contracts to be dropped. At least a few million now between us

Happy holding astute investors and remain patient for the real rerate

Don’t take my word for it SEVERELY UNDERVALUED COMPARED TO OUR USA 🇺🇸 PEERs, a great article from 2 days ago

The results were so good that the UK Department of Health through the National Institute of Health and Care Research are co-funding the trial.

800k for a phase III trial is UNHEARD OF

The BoD steering this in the right direction

https://www.thisismoney.co.uk/money/markets/article-14996499/SMALL-CAP-IDEA-Ketamine-drip-therapy-firm-taking-alcoholism.html

Haven’t checked in her for a few weeks but nice to step changes in the SP following the period of consolidation. Did top slice my entry a while back so looking to get another decent entry to top up and double my holdings and sit back. Between this and Fusion antibodies it is nice to see a sea of blue after almost a year of holding

Good luck ALTH serious potential here, aptamer binders are here to stay

What you fail to realise bot00 is that they have a phase 3 drug in preparation ready to be out licensed. It had an 86% success rate in phase II. They already directly raised £1 million as announced last month. These assets are not going to fail

When the BOTs start spamming this board it means good news is around the corner

THIS IS DETERMINED FOR SUCCESS OF THE HIGHEST MAGNITUDE

The GSA was only signed less then a month ago, conversations continue behind closed doors to steer this to conclusion. This cannot be done over a matter of days, exercise some patience folks and hold steady, the news will follow in short order as Conrad do the necessary.

Stay vested astute investors

Real investors won’t be batting an eye lid with holding this stock. Please ignore any DISPLACED placing fears. Some people are desperately trying to get in at a lower price.

Buy hold and then repeat

Keep the board for legitimate SVNS-centric focused discussion

It is pretty much common knowledge now the amount of times the CEO and BOD have alluded to the near term out licensing discussions of :

· The Company's lead programme, SVN-001, in Phase III

The ancillary programmes;

SVN-002

SVN-SDN-14

are worth a whole new share company in their own right.

To have multiple assets with near to long term potential is some truly remarkable work by SVNS. They have really strategically and methodically worked out every move with meticulous detail.

When business meets science and aligns effortlessly everybody wins

Anything under 0.5 buy and hold

These incremental increases are making my few million shares look robustly healthy. Still holding for the actual exponential explosive Rerate which sends this to triple figures

Buy-hold and then repeat, good luck all vested astute investors

What an amazing movement of the SP during traditional quiet periods this has rocketed this month